Jennifer Kiser

Jennifer Kiser PharmD

Associate Professor
Pharmaceutical Sciences
  • Skaggs School of Pharmacy and Pharmaceutical Sciences

Email Address:

Primary Phone: 303-724-6131

Recent Publications

Co-Director, Colorado Antiviral Pharmacology Laboratory

Associate Director, University of Colorado Center for Translational Pharmacokinetics and Pharmacogenomics

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
Fourth Floor Room 4102

Research Interests:

  • Intracellular pharmacology of nucleos(t)ide analogs
  • Drug interactions with antiviral therapies
  • Pharmacokinetics of antivirals in patients with viral hepatitis and special populations with HIV (pregnant women, children, those coinfected with viral hepatitis)
  • Effects of recreational drug use on antiviral pharmacology and adherence

Representative publications:

MacBrayne CE, Marks KM, Fierer DS, Naggie S, Chung RT, Hughes MD, Kim AY, Peters MG, Brainard DM, Seifert SM, Castillo-Mancilla JR, Bushman LR, Anderson PL, Kiser JJ. Effects of Sofosbuvir-Based Hepatitis C Treatment on the Pharmacokinetics of Tenofovir in HIV/HCV-coinfected Individuals Receiving Tenofovir Disoproxil Fumarate. J Antimicrob Chemother 2018;73(8)L2112-2119.

Wu L, Rower JE, Burton, JR, Jr., Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D’Argenio DZ, Kiser JJ. Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus. Antimicrob Agents Chemother. 2015;59(4):2179-88.

Kiser JJ, Burton JR, Everson GT. Drug interactions in viral hepatitis. Nature Reviews Gastroenterology & Hepatology 2013;10(10):596-606.

Kiser JJ, Rutstein RM, Samson P, Graham B, Mofenson L, Smith E, Fenton T, Brundage RC, Fletcher CV. Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents; Infant Maternal Pediatric Adolescent AIDS Clinical Trials Group P1020A. AIDS 2011;25(12):1489-96.